OBJECTIVES: Oesophagectomy is a complex operation with the potential for prolonged recovery. The aim of this study was to evaluate healthcare resource utilization, specifically emergency department (ED) visits within 1 year of oesophagectomy, and to identify risk factors for ED visits and frequent ED use (FEDU).
INTRODUCTION
Oesophageal cancers are of increasing incidence in North America [1, 2] . Surgery is the primary treatment for operable cancers of the oesophagus either alone or combined with chemotherapy or chemoradiation therapy [1, 2] . Oesophagectomy is among the most morbid of surgical procedures with associated complications that may persist for sustained periods after surgery or arise de novo [3] [4] [5] . This has implications on quality of life of patients and resource utilization [6] . Emergency room visits following the operation are common and have consequences in terms of health resource utilization and quality of life [6] [7] [8] [9] . Despite this, there is a significant gap in the literature on the incidence of emergency department (ED) visits after oesophagectomy. This gap in the literature is important to address because isolated and frequent ED utilization can have significant effects on healthcare costs and the quality of life of vulnerable patients whose quality of life has already been compromised by their oesophageal cancer and its treatment. As part of a quality improvement initiative, we aimed to identify the incidence of ED visits. This would hopefully allow us to design targeted interventions to reduce the burden of ED visits for both our patients and our healthcare system.
In determining what factors may affect patient outcomes after oesophagectomy, there is mounting evidence to suggest that oesophagectomy mortality rates are reduced in high-volume centres, but resource utilization has not been as strongly associated with hospital volume [8, 10] . Thus, treatment, patient and geographic factors may be associated with increased readmission following oesophagectomy. To date, all studies of emergency room visits have evaluated a time window of 30 days after discharge from oesophagectomy hospitalization. Since the impact of oesophagectomy has long-term effects, limiting evaluation of readmission to 30 days likely underestimates the true burden of resource utilization. The objective of this study was to determine the incidence of isolated and frequent ED visits within 1 year of oesophagectomy and to identify factors associated with increased ED utilization. This may identify factors amenable to both local-and system-level interventions for quality improvement in the delivery of oesophageal cancer care.
METHODS
This study was approved by our research ethics board. We conducted a retrospective cohort study of consecutive oesophagectomies for cancer in all hospitals in the province of Ontario using linked health administrative data. Ontario has a single-payer healthcare system with a population of 13.8 million people. Our cohort definition was all patients who were diagnosed with oesophageal/gastric cancer AND who also had an oesophagectomy. Gastric cancer was included to capture patients who had gastroesophageal junction tumours but were labelled as gastric cancer. All patients in Ontario who developed oesophageal cancer between 1 January 2000 and 31 December 2012 were identified from the Ontario Cancer Registry (OCR) [10] . The OCR contains information on all new cases of cancer diagnosed since 1964 in Ontario and has been estimated to be more than 95% complete for incident cases of all cancer sites combined [10] . Oesophagectomies were identified through linkage to the Canadian Institute for Health Information Discharge Abstract Database, which contains information on every patient discharged from a hospital in Ontario [10] . Demographic information was obtained from the Registered Persons Database, a roster of virtually all individuals living in Ontario [10] . Data were obtained from the Institute for Clinical Evaluative Sciences (ICES) data repository. The ICES data repository consists of deidentified individual-level, coded and linkable health data sets on all Ontarians [10] . Thus, this cohort study represents essentially a total sampling of all oesophagectomies performed in this province. Ontario has a geographic land mass of approximately 1 million km 2 and has 14 different health regions called Local Health Integration Networks (LHINs). The mandate of LHINs is to plan and fund local healthcare within that region. Oesophageal cancer surgery is intended to be delivered in a designated Thoracic Surgery Center within a patient's LHIN; however, patients can receive oesophageal cancer surgery outside their LHIN based on referral patterns and availability of appropriate centres [11, 12] .
Statistical analysis
For univariable analysis, normally distributed continuous data are reported as means with standard deviations and analysed using independent sample t-tests. Data that were not normally distributed are reported as medians with interquartile ranges and analysed using the Mann-Whitney U-test. The Fisher's exact tests were used for univariate analysis of categorical data. Multivariable logistic regression was used to identify factors independently associated with ED visits. Demographic, socioeconomic (income and rurality), medical or surgical (comorbidity and the use of minimally invasive surgery) factors were assessed. A forced-entry method was used to simultaneously control for these factors. We performed 2 regression analyses to identify risk factors for ED visits at different time points (90 days and 1 year) to identify whether there were any different short-term and long-term risk factors. We also performed a regression analysis to identify risk factors for frequent ED use (FEDU) (defined as > _3 ED visits) within 1 year. Competing risk analysis was not used for the competing risks of ED visits and mortality after hospital discharge. Although it is true that experiencing death at home after discharge prevents a patient from presenting to the ED, our purpose was in identifying burden of resource utilization incurred by ED visits; thus, competing risk analysis is not necessary as patients who experience death at home after discharge would not be expected to increase the burden of ED visits or resource utilization.
Comorbidity status was defined using the Johns Hopkins Adjusted Clinical Groups (ACG) due to a high rate of missing Charlson Comorbidity Index (CCI) data at the population level [13] . The ACG are a person-focused, diagnosis-based method of categorizing comorbidity status based on the International Classification of Disease codes and burden of disease incorporating data on longitudinal assessment of health records [13, 14] . This has been shown to have similar and sometimes better discriminative or predictive ability for 1-year mortality than CCI in the Ontario health system [14] . Rurality was defined using the rurality index of Ontario, which was a validated and data-driven index derived or calculated using a person's postal code and the following elements: (i) measure of community population and population density, (ii) travel time to the nearest basic referral centre and (iii) travel time to the nearest advanced referral centre [15] . A 2-sided alpha of 0.05 was used for all tests of significance. Statistical analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA 2011).
RESULTS
There were 3344 oesophagectomies with in-hospital mortality of 5.8% (n = 193). Median length of stay was 13 days (interquartile range [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] for those who did and did not have ED visits, with no numerical and statistical difference between groups. There was no correlation between length of hospital stay and number of ED visits within 1 year; the Pearson correlation coefficient was r = -0.03 and P = 0.15. The majority of patients were discharged home. The discharge location details were only reliably captured in this database after 2002. Among those patients with available data, the discharge location was as follows: 940 (37.8%) patients were discharged home without any supports, 1403 (56.4%) were discharged home with some supports (i.e. home care for feeding tube care) and 145 (5.8%) were transferred to another facility (either continuing care facility or rehabilitation centre). Although this database does not provide data on the postoperative nutritional state of these patients, the general practice is to send people home on a postoesophagectomy soft diet with ongoing enteral jejunostomy tube feeding and request that they return in 4-6 weeks for reassessment in the clinic. Based on procedure codes and discharge abstracts, this database shows that 71.4% (n = 2388) of patients had jejunostomy. This may be an underestimate because surgeons may have done a jejunostomy but may not have not billed for it.
Of those discharged from hospital, 16.4% (n = 549), 36.0% (n = 1203) and 55.8% (n = 1866) had ED visits within 30 days, 90 days and 1 year, respectively (Fig. 1) . The majority of these ED visits did not result in subsequent hospital readmission with 27% (n = 504) of these ED visits resulting in a formal hospital readmission. ED utilization is associated with higher 1-year mortality and 2-year mortality. Higher comorbidity status, rural status and receipt of chemotherapy and/or radiation therapy were independent risk factors for ED visits at 90 days and 1 year after oesophagectomy (Tables 1 and 2 ). Although receipt of chemotherapy alone was an independent risk factor for ED visits within 1 year, it was not an independent risk factor for ED visits at 90 days (P = 0.54) ( Tables 1 and 2 ). Thoracoscopic-assisted surgery was independently associated with 'decreased' ED visits but only at 1 year and not at 90 days [adjusted odds ratio = 0.67, 95% confidence interval (CI): 0.45-0.99, P = 0.049]. Eight hundred and thirteen (24.3%) patients had FEDU. Higher comorbidity, rural status and receipt of chemotherapy and/or radiation therapy were independent risk factors for FEDU (Table 3) . Older patients were more likely to have FEDU (P < 0.05) ( Table 3) . One health region (LHIN A) had more ED visits (P = 0.04) and more FEDU (P = 0.001) when compared with the reference standard (i.e. the highestvolume health region) (Tables 1-3 ). One health region (LHIN B) had more ED visits (when compared with the reference standard) at 90 days but not at 1 year, whereas another health region (LHIN G) had the opposite pattern; neither of these 2 health regions demonstrated significantly more FEDU (Tables 1-3 ). There were higher ED visits and more FEDU in the later years of the study period (both P < 0.0001) (Tables 1-3 ). Those with ED visits were likelier to experience mortality at 1 year (21.7%, n = 404) when compared with those without ED visits (16.5%, n = 212).
DISCUSSION
Using a population database approach, we investigated treatment-, patient-and geographic-related factors that may be associated with increased ED visits within 1 year following oesophagectomy. We assessed whether risk factors for ED use were different at 1 year when compared with risk factors in the shortterm time window typically assessed by studies of ED visits (i.e. 90 days). We also assessed for risk factors of FEDU. Higher comorbidity status, rural status and receipt of chemotherapy and/or radiation therapy were consistently found to be independently associated with increased risk of isolated ED visits at both 90 days and 1 year and at increased risk of frequent ED visits within 1 year of oesophagectomy. In addition to being a marker of increased health resource utilization, ED visits also conferred increased risk of mortality. Those with ED visits were likelier to experience mortality at 1 year (21.7%, n = 404) when compared with those without ED visits (16.5%, n = 212).
In addition to treatment-and patient-related risk factors for higher readmission, we identified system-level risk factors that require further evaluation. There was higher risk of ED visits and more FEDU in the later years of the study period. This highlights a limitation of our study and studies similar to these: it is unclear whether these ED visits were necessary or unnecessary. It is also unclear whether the use of ED visits leads to a reduction in the rate of readmissions (which are more expensive). Our previous work (submitted for publication) has shown that readmission rates actually decreased in this patient population over the same period. Over this period of time, regionalization efforts led to the concentration of oesophagectomies into 15 centres in Ontario that performed at least 20 oesophagectomies annually [11, 12] . Thus, although this may have resulted in lower levels of readmission, it may have increased ED use in the patients who were further away from an oesophagectomy centre. Certainly, this is supported by our finding that rural status was a consistent risk factor for ED visits and FEDU. The definition of rural status incorporates travel time to the nearest basic and advanced referral centres [15] . Our future work will focus on the health resource utilization trade-offs between ED visits and readmissions as they relate to costs. One health region (LHIN A) had more ED visits and more FEDU when compared with the reference standard (i.e. the highest-volume health region) (Tables 1-3 ). Although the identity of the different health regions is masked by the population database, we plan to make a request to identify the health regions to further explore what factors contribute to higher ED utilization within that health region. The ultimate aim would be to assess whether there are system-level interventions that could be applied to address those risk factors. Income did not appear to have an independent effect on ED visits. This may reflect the effect of our universal healthcare system, where everyone has health coverage.
Virtually, all studies investigating ED use postoperatively focus on 30 days after discharge [16] [17] [18] [19] . There is a paucity of data about ED utilization after oesophagectomy with estimates ranging between 13 and 15% [20] . Our results, which demonstrated an incidence of 16.4% at 30 days, concur with and add to the limited literature in this area. However, resource utilization and ED visits continue to occur well beyond the 30-day window. Our study shows that the incidence more than doubles to 36.0% at 90 days and encompasses more than 50% of patients at 1 year. This represents a significant burden for patients and the healthcare system. Manzano et al. [21] found similar results in their cohort study of patients in a different healthcare system in the state of Texas. Although they did not focus on patients with oesophagectomy for oesophageal cancer, they looked at a heterogenous group of resected and non-resected gastrointestinal cancers; they found that oesophageal cancer patients had the highest burden of ED visits and readmissions, ranging from 9.4% at 1 month to 66% at 2 years for the oesophageal cancer subgroup. In that study, it was likely that a significant proportion of the unplanned readmissions (including ED visits and readmissions) in the 2nd year after surgery were related to recurrence or metastasis [21] . Most notably, the oesophageal cancer subgroup showed the greatest incidence of unplanned readmissions when compared with other gastrointestinal cancers [21] . Although their results are in line with our findings, it should be noted that our healthcare systems are different and the focus in our study was purely on resected oesophageal cancer patients [21] . Although we could not identify any similar studies looking at oesophageal cancer patients treated non-operatively, there are some studies that suggest that non-operative treatment (i.e. definitive chemoradiation therapy) is likely associated with even higher rates of ED visits [22] . Odelli et al. [22] conducted a small retrospective study of 48 patients in Australia and found that unplanned hospital admissions ranged from 46 to 75%. A protocol of riskstratified nutrition support was associated with the lower unplanned hospital admissions rates of 46% [22] . Understanding the true burden of and the risk factors for ED visits, especially frequent ED visits, provides opportunities for designing patient-, treatment-and system-level interventions to try to optimize health resource utilization and improve outcomes for patients.
Limitations
A limitation of this study is that it is based on retrospective data. Another limitation is the inherent value judgement placed on ED visits as the potential marker of poor quality care [8, [23] [24] [25] . It is not clear that ED visits are unnecessary or inappropriate in all cases. In some cases, ED visits may be quite appropriate and may actually save significant resources by preventing worsening cascade of complications or reducing readmissions. A related limitation is that the cause of ED visits is difficult to reliably disentangle from database studies such as this. As a result, the main purpose of this article and study is to assess the burden of the problem across our entire single-payer health and to identify risk factors to potentially target. These results will be shared with the thoracic surgical community in our province and to the key policy makers in the oesophageal cancer care. Further work is necessary to further explore the potential solutions that may provide closer and more frequent planned follow-up for patients with higher comorbidity status, older age and also those who received chemoradiation. Our study has strengths. First, we used a robust population database in a single-payer, universal healthcare system. Our data repository has 100% coverage of the entire population of Ontario and, thus, is not subject to sampling bias. Moreover, it is linked to socioeconomic data allowing us to evaluate these determinants of health. Similar to many population databases, it has the ability to capture events that occur at non-index hospitals. Unlike some population databases, our database allowed for the use of a validated rurality index that incorporates population density and travel times to the nearest basic and advanced referral centres. This is especially important in the context of our regionalized oesophagectomy care.
CONCLUSION
In conclusion, there is a high burden of ED visits within 1 year of oesophagectomy. Our study shows that more than half of oesophagectomy patients have 1 or more ED visits within 1 year of being discharged home. Furthermore, approximately a quarter of patients are frequent ED users (> _3 visits in 1st year). We identified patient-, treatment-and system-level factors that are independently associated with increased readmission. This provides opportunities for designing patient-, treatment-and system-level interventions to try to optimize health resource utilization. Some of these patient-and treatment-related risk factors (i.e. higher comorbidity status, use of radiation and chemotherapy) are likely not modifiable. However, perhaps providing increased supports or closer clinical follow-up in those patients may serve to reduce or mitigate the risks of increased ED utilization. Although it may not be possible to successfully reduce isolated ED visits, especially in rural patients, it may be easier to reduce the number of frequent ED users. Further study is needed to assess whether better upfront institution of supports for rural patients (i.e. such as telemedicine) may reduce FEDU.
